outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.2195182961,0.0281527644,1.7116714239,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.3515390706,0.1710118015,0.7226385376,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,1.349426786,0.8548868243,2.1300511354,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.3850074399,0.0491862025,3.013664834,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4823283321,0.2223858996,1.0461122777,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.1776278813,0.9830311801,4.823919409,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.385516989,0.0492029877,3.0206163453,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4781535868,0.220349829,1.0375812571,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.2059269715,0.9871498687,4.9294579856,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.3842935277,0.049192008,3.0021444812,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4820076062,0.2224094718,1.0446107826,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.1717532256,0.9565667692,4.9306668648,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.3849868845,0.0491835166,3.0135076034,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4822356388,0.2223328343,1.0459598201,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.1796787838,0.9820505306,4.8378361931,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.384801556,0.049196313,3.0098238735,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4777157624,0.2203249398,1.0357989882,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.2011254828,0.9647092021,5.0221905009,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.3851851399,0.0491119724,3.0210065843,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4707046258,0.2169147934,1.0214280052,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.235488928,1.0028722588,4.9830980001,1,1
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.0525703393,0.5798504547,1.9106725024,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.8952621719,0.6166496508,1.2997564425,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.1477011757,0.9355102027,1.4080209759,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7870553875,0.8263792469,3.8645294763,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9294302688,0.5968152195,1.4474172179,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.103885874,0.7795955192,1.5630721225,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7854205853,0.8255358971,3.8614028508,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9302769927,0.597369688,1.4487097363,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.1063040748,0.7804173107,1.568274677,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7415094021,0.8051573169,3.766785613,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9195303447,0.5904619848,1.4319906728,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.067361787,0.7487865795,1.5214765001,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7865881865,0.8260845158,3.8638871534,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.928098977,0.5961134128,1.4449728737,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.1108338642,0.7823933089,1.577150341,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7444153331,0.8066682829,3.772287716,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.920572617,0.5914248188,1.4329022325,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0850865103,0.7567977843,1.5557824815,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7692928761,0.8175148867,3.8291624195,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9233060033,0.5924007205,1.4390495255,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.1107006497,0.781903753,1.5777593194,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.2906454841,0.1594418561,0.5298156925,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.5734208495,0.4394875292,0.7481701956,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.7354564579,0.6018905605,0.8986620442,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.4029364283,0.1730038655,0.938463223,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7173785506,0.523931071,0.9822513177,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6321079537,0.4755311849,0.8402402993,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.4028247611,0.1728794985,0.938617879,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7188920039,0.5250301573,0.9843352922,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6329900883,0.4765822917,0.8407287867,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.3947196416,0.1700028542,0.916476351,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7107398389,0.5191293572,0.9730736888,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6100053634,0.4607037067,0.8076916637,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.4028805201,0.1729806962,0.9383284782,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7193582938,0.5253633623,0.9849875189,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6301342775,0.4743827832,0.8370228046,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.3951614099,0.1701321429,0.9178309119,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7140106879,0.5216039306,0.9773915275,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6061623133,0.4586898138,0.8010484188,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.396065329,0.1704489495,0.9203209831,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7080033763,0.517007869,0.9695573528,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.624592545,0.4699663983,0.8300930635,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,0.3884056841,0.1499230965,1.0062423929,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.6466197544,0.4161195368,1.0048004713,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,0.8434646199,0.6691662521,1.0631626487,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.4013047678,0.41117965,4.7756620554,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8572834,0.5109104389,1.4384807435,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.0853328772,0.7487012462,1.5733210812,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.403829763,0.4114190703,4.7900988202,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8603852958,0.5126655573,1.4439488799,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.091200358,0.7503763295,1.5868280681,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.3749821252,0.4050153605,4.6679114643,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8515818253,0.5079028987,1.4278154487,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.0518643788,0.7221530112,1.5321111376,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.4013860357,0.4112481972,4.7754198911,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8580929476,0.5114557706,1.4396621351,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.0750973931,0.742675767,1.5563109179,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.3795987132,0.4060697362,4.6871077544,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8554505648,0.5102421663,1.4342124525,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.0460154885,0.7167924135,1.5264508684,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.4078078482,0.4148602205,4.7773270122,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.857241166,0.5109740699,1.4381598988,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.1015881745,0.7547607159,1.6077897017,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.2301664266,0.0540815102,0.9795692427,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.5021239062,0.3253245142,0.7750058975,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,0.9120738607,0.721113732,1.1536026711,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1265615296,0.0276070073,0.5802085165,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7788677466,0.4361904204,1.3907571974,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1455415078,0.7581858643,1.7307963759,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1259131174,0.0273074006,0.5805793583,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7826125005,0.4379077706,1.3986559888,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1468598325,0.7584077917,1.7342747395,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1239952396,0.0269969413,0.5695022729,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7729851868,0.4329642476,1.380035655,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1131628054,0.7288712567,1.7000690039,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1265602155,0.0276067189,0.5802025303,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7787922806,0.4363895132,1.3898533259,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1457949649,0.7586418347,1.7305216263,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1238351319,0.0268126809,0.5719360909,1,1
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7779408948,0.4357852949,1.3887390026,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1144742725,0.7294932091,1.7026243543,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1254546112,0.0272012128,0.5786087412,1,1
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7770172675,0.4367052176,1.3825248925,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1606139527,0.7675666594,1.7549286836,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,6.4915999893,0.6769843414,62.247924869,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8990523205,0.4399705686,1.8371571482,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.8704335739,0.6008615672,1.2609470266,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.434653173,1.5768912284,151.07479469,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8689072514,0.4071775852,1.8542273419,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.777584661,0.4573435509,1.3220650074,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.508539126,1.5815258861,152.07767886,1,1
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8701146826,0.4078112505,1.8564950329,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7882607949,0.4627377284,1.342780246,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.055323671,1.5348004856,147.68223816,1,1
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8611827431,0.4037319842,1.8369506162,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7530027787,0.4408367668,1.2862202689,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.434602524,1.5768860984,151.07429466,1,1
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8689445956,0.4072051534,1.8542611851,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7776990792,0.4570426723,1.3233247012,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.199395077,1.5466315456,149.37081258,1,1
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8629879976,0.4045659979,1.8408573333,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7657333406,0.448105319,1.3085038808,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.561060209,1.5902178196,152.27259552,1,1
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8642068811,0.4056963004,1.8409177813,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7985656139,0.4665316265,1.3669106304,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,0.8249505005,0.5448514285,1.2490438543,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9708091895,0.8353044245,1.1282958103,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,0.9107124659,0.805580464,1.0295646837,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2740600008,1.1413252641,4.5310036058,1,1
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9447854093,0.785201364,1.1368032591,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0089483261,0.8247770755,1.2342446885,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2570175239,1.1310453342,4.5039115137,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9447879481,0.7847954623,1.1373973345,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0070379789,0.8231754447,1.231967617,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2906100806,1.1499384817,4.5627610735,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9480733166,0.7877715192,1.1409945545,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0189157484,0.8312601975,1.2489342152,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2768610243,1.1431614247,4.5348767132,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.94217548,0.7839970863,1.1322677732,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0066423422,0.8200117116,1.2357491859,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2681198883,1.1370788465,4.5241962275,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.943590421,0.7845989375,1.1348000105,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0102712471,0.8228594279,1.24036738,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2482166855,1.1243953706,4.4952855526,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9403461341,0.7808583503,1.1324087802,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0076616084,0.8229901462,1.2337716577,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.1781171283,0.7644419597,6.2060881988,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,2.1083244277,1.4442273399,3.0777923735,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,2.2570555664,1.554274341,3.2776065945,1,1
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.565397207,0.5267095282,4.6524095053,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4861455924,0.9470083956,2.3322166223,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7459938046,1.0185252182,2.9930475075,1,1
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5451851506,0.5187855946,4.6022811245,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4690361917,0.9343562132,2.309683718,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7543711348,1.0220753862,3.0113415508,1,1
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5519082132,0.5211840726,4.6210527701,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4817807866,0.9440084892,2.3259052484,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7283273003,1.0027653804,2.9788775274,1,1
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5653816579,0.5267011317,4.6523912473,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4867125404,0.9472794448,2.3333285545,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7464049938,1.0187478223,2.9938031138,1,1
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5297148563,0.5125574895,4.5653952765,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4650675148,0.9316166563,2.3039764354,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7375358909,1.0069697788,2.9981346371,1,1
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5398975747,0.5165732899,4.5904126033,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4634000718,0.9300220342,2.3026763791,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7789922862,1.0380064937,3.048934254,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.584236942,0.8680546662,2.8913002672,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.4929210776,1.1073634418,2.0127207201,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.8983206646,1.2128476348,2.9712069697,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.7993934681,0.8979975531,3.6055965208,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5753667854,1.1271748751,2.2017706065,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.997876329,1.0808405438,3.6929682633,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.8033647967,0.8992017725,3.6166794699,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.579391952,1.1295309711,2.2084201337,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,2.0070075568,1.0825826686,3.7208053017,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.7828461921,0.8882409446,3.5784665906,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5706998695,1.1235535886,2.195799208,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.9709076996,1.0620613376,3.6574885299,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.799428321,0.8980065521,3.605700064,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5782136429,1.1292343316,2.205705435,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.9984231941,1.0819499747,3.6912014013,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.7899631281,0.8905275492,3.5978314233,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5778513118,1.1282513653,2.2066135604,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.9793603033,1.0628690636,3.6861240434,1,1
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.8040086734,0.9001226972,3.6155596384,1,0
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5744761898,1.1264676111,2.2006627159,1,1
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,2.0009978793,1.0748436364,3.7251860433,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,0.8517546471,0.3776162563,1.9212254949,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,1.0611139709,0.7842416375,1.4357346069,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,2.0129041888,1.3446976937,3.0131555162,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,1.0013826476,0.372122557,2.6947229833,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9429578974,0.6556655427,1.3561328732,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.6043954028,0.9539350342,2.6983856513,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,1.000011895,0.3710531967,2.6950954718,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9406259037,0.6534128149,1.3540859172,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.6090199548,0.9564866496,2.7067238375,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,0.9968019623,0.3701791967,2.6841436821,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9415698221,0.6541378855,1.3553009993,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.5959126186,0.9513993886,2.6770430133,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,1.0014006209,0.3721315062,2.6947549102,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9438280209,0.6563205009,1.3572809805,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.6062769048,0.9550861941,2.7014582671,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,0.9963751806,0.3695381188,2.686498226,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9401969618,0.6526379542,1.3544574313,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.6025656728,0.9552243856,2.6886004737,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,0.9966925279,0.3700419552,2.684549634,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9353745731,0.6501326791,1.3457646727,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.605858033,0.9537657054,2.7037877413,1,0
Kidney disease,Amyloidosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,1.2028746E-7,2.601557E-8,5.5616977E-7,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,3.1217999638,0.2830548568,34.430198879,1,0
Kidney disease,Amyloidosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,0.8086637289,0.0579580004,11.282946645,1,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,1.2048059E-7,3.556197E-8,4.0817682E-7,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,3.1326247767,0.2781263174,35.283744753,1,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,0.8170363156,0.0581576726,11.478250613,1,0
Kidney disease,Amyloidosis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,2.4060866E-8,1.379355E-9,4.1970724E-7,0,0
Kidney disease,Amyloidosis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,3.0802860391,0.2814505687,33.71164651,1,0
Kidney disease,Amyloidosis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,0.7717330625,0.0540394149,11.021065297,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,838,1763,4.3674585432,0.3962492741,48.138117522,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,1.1502592139,0.2552760235,5.1830024648,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1109,5189,2.4453634434,0.8184100321,7.3066093226,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,838,1763,8.131152033,0.6186204464,106.87592654,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.9582058134,0.1983586188,4.6287798649,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1109,5189,2.2418609491,0.6249430693,8.0422373851,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,838,1763,8.3094673147,0.6308341666,109.45387981,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.9548417672,0.1975855247,4.6143198082,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1109,5189,2.2630245665,0.6285951741,8.1471834333,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,838,1763,8.0599657771,0.6215009139,104.52607048,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.9548282635,0.197883215,4.6072478289,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1109,5189,2.2145682377,0.5950518668,8.2418235343,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,838,1763,8.1302268778,0.6185451047,106.86462246,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.9591054748,0.1986312294,4.6311112026,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1109,5189,2.2398707493,0.6255897766,8.0196658605,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,838,1763,8.2138388712,0.6379770818,105.75168126,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.9505449884,0.1972258245,4.5812244775,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1109,5189,2.2350475744,0.5954865854,8.3888332375,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,838,1763,8.3876547649,0.6341955445,110.93227171,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.9588058234,0.1980964946,4.6407111284,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1109,5189,2.2910077463,0.6434531907,8.157106949,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,7024004.6476,1726602.0444,28574413.802,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,1.0592396826,0.1722419745,6.5140260298,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,2.1700513031,0.4151331452,11.343644112,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2887623.6353,658751.0253,12657847.865,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.6479246257,0.1067131032,3.9339716302,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,6.5010332999,0.8580720226,49.253947052,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,3405514.9609,771522.58815,15032005.967,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.6551847007,0.1072025056,4.0042626775,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,6.502910595,0.8445847986,50.069390637,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2882434.3428,662294.29836,12544918.115,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.6472431058,0.1067676003,3.9236962975,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,6.467265854,0.7978508395,52.422740639,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,8241501.5459,1880109.1374,36126811.142,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.6486923017,0.1068396144,3.9386299222,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,6.523364307,0.8645055237,49.22384035,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,9497633.6919,2194404.9938,41106835.793,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.6569364612,0.1076174409,4.0101819049,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,6.5231303913,0.7671707106,55.465139001,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1703117.0484,384186.12291,7550006.3842,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.6636815165,0.1085545634,4.0576198891,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,6.5299677961,0.8439569055,50.524474813,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,0.9964476765,0.9093034549,1.0919434724,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,1.0256816201,0.2890304749,3.6398334335,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1103,5177,2.6878916019,1.5610525908,4.6281344434,1,1
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.0392844657,0.8903429041,1.2131418082,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.8180648954,0.2241872528,2.985139274,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1103,5177,2.5483758194,0.7986173846,8.1318281345,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.0317615546,0.8695749579,1.2241979785,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.8208012898,0.2247267706,2.9979283535,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1103,5177,2.5592787651,0.809516082,8.0911398092,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.0707854309,0.9185065484,1.2483105765,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.8258730549,0.2262303005,3.0149201995,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1103,5177,2.6281797731,0.8180659235,8.4434869139,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.0393721807,0.8903502873,1.2133365322,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.8183573957,0.2242652121,2.9862358986,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1103,5177,2.5482862815,0.799632494,8.1209343306,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.0786319235,0.8969646542,1.2970932813,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.822449007,0.2250156808,3.0061121364,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1103,5177,2.6417966824,0.8206025525,8.5048354895,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.0415361556,0.8835512627,1.2277698072,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3921,6307,0.8155961057,0.2230747296,2.9819469415,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1103,5177,2.5905256015,0.8261914135,8.1226006254,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,835,1761,0.5219513753,0.1970706101,1.3824143439,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3903,6283,0.9898129968,0.6591906522,1.486261623,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1073,5105,1.2017041978,0.9148754621,1.5784585323,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,835,1761,0.4442209441,0.1541945711,1.2797613152,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3903,6283,1.2861855488,0.798300561,2.0722436471,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1073,5105,1.2039977726,0.6413902014,2.2601072379,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,835,1761,0.4445658878,0.1541273316,1.2823087671,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3903,6283,1.2909627966,0.8007845635,2.0811901454,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1073,5105,1.2148416804,0.6449091844,2.2884467209,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,835,1761,0.4495105767,0.1560897267,1.2945102974,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3903,6283,1.2923565209,0.8017494764,2.0831761373,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1073,5105,1.2271681382,0.6472156022,2.3268005811,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,835,1761,0.4442085629,0.1541896043,1.2797311998,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3903,6283,1.2860502771,0.7981813174,2.0721172987,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1073,5105,1.204595084,0.6417484982,2.2610872026,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,835,1761,0.4486844281,0.1555267945,1.2944246471,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3903,6283,1.2967094988,0.8037776075,2.0919412391,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1073,5105,1.2376701388,0.6502971455,2.3555806498,1,0
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,835,1761,0.4415901523,0.1530504655,1.2741017289,1,0
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3903,6283,1.2718324329,0.7882668242,2.0520434042,1,0
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1073,5105,1.2227395418,0.6410239682,2.3323495861,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.9603309E-6,2.4776833E-7,0.00001551,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6306,0.7675550971,0.0705657883,8.3488166265,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5189,0.5690806132,0.0727115453,4.4539384049,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,7.055973E-7,9.755022E-8,5.1037051E-6,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6306,0.3254282544,0.0260018088,4.0729300665,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5189,0.125669047,0.0155401809,1.0162500341,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,9.6057242E-7,1.3380952E-7,6.8956183E-6,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6306,0.3185669506,0.0244025,4.1587911942,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5189,0.133186044,0.0165291171,1.0731681677,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,7.3230212E-7,1.0256273E-7,5.2286673E-6,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6306,0.3290416105,0.0263311209,4.1118029768,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5189,0.1301133662,0.0158972069,1.0649347527,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,6.7542688E-7,9.1253264E-8,4.9992893E-6,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6306,0.3259785948,0.026038226,4.0810016848,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5189,0.1251949087,0.0154663495,1.0134107689,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,3.7016229E-7,5.7043317E-8,2.4020364E-6,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6306,0.3212561078,0.0248696295,4.1498602518,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5189,0.1368925893,0.0169344485,1.106595292,1,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,3.2752905E-7,4.460143E-8,2.4051982E-6,0,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6306,0.3011143269,0.0230006498,3.9420554899,1,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5189,0.1347523394,0.0170726326,1.0635848289,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1764,3.89591E-6,9.5828856E-7,0.0000158388,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,1.5314730166,0.6901712886,3.3983007394,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5185,0.7691233751,0.26200649,2.257771424,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1764,1.9249944E-6,4.7806398E-7,7.7512713E-6,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,1.4629983148,0.6088883926,3.515199329,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5185,1.4585236743,0.3125496503,6.8062508036,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1764,1.9140173E-6,4.7790129E-7,7.6657301E-6,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,1.4734080065,0.6126001019,3.5437982249,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5185,1.4834049433,0.3167221615,6.9476989395,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1764,1.9442791E-6,4.8498139E-7,7.7945696E-6,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,1.4677313416,0.6108569558,3.5265789656,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5185,1.4755194935,0.3059675264,7.1156498248,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1764,1.8187534E-6,4.5305891E-7,7.3011782E-6,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,1.4599213098,0.6074264101,3.5088534108,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5185,1.4617758671,0.3118784957,6.8513498523,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1764,1.818815E-6,4.5320443E-7,7.2993286E-6,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,1.4733018621,0.6120658106,3.5463806985,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5185,1.4942799836,0.30932184,7.2186065788,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1764,1.9812719E-6,4.9146804E-7,7.9871687E-6,0,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,1.4710072741,0.6108401216,3.542436595,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1108,5185,1.526865241,0.3354014583,6.9508268567,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1765,0.4810820239,0.1981416524,1.1680528091,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3915,6298,0.5914423899,0.3694707157,0.946770842,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1083,5071,0.8619242224,0.676199522,1.0986599976,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1765,0.462701694,0.1701963723,1.2579166922,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3915,6298,0.9371395045,0.5513080854,1.5929939615,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1083,5071,0.6658589779,0.470226322,0.9428825179,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1765,0.4596318723,0.1689885617,1.2501524123,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3915,6298,0.9384113375,0.5520221301,1.5952545927,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1083,5071,0.6648848621,0.4682608891,0.944071756,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1765,0.4717340601,0.173780975,1.2805373169,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3915,6298,0.9447567571,0.5556525983,1.6063370042,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1083,5071,0.6836347978,0.4803993365,0.9728500878,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1765,0.4627029395,0.1701968161,1.2579201837,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3915,6298,0.9371630998,0.5513185144,1.593044044,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1083,5071,0.6659989549,0.469958515,0.9438165151,1,1
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1765,0.466049496,0.1714614323,1.2667696154,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3915,6298,0.9449223218,0.5556834435,1.6068108645,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1083,5071,0.683767911,0.4780074747,0.9780988391,1,1
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1765,0.4632846607,0.1701062905,1.2617562598,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3915,6298,0.9370392605,0.5519923198,1.5906789717,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1083,5071,0.6474412602,0.4543394335,0.9226145795,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,834,1753,0.6851259315,0.3750702556,1.2514923136,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3895,6272,1.091380608,0.7876158345,1.5123002604,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1062,5024,0.7537886799,0.5989186067,0.9487054961,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,834,1753,1.4095597406,0.4720442979,4.2090512922,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3895,6272,1.4429318541,0.9938407847,2.0949556181,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1062,5024,0.9870965697,0.6418520916,1.5180438774,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,834,1753,1.4171069063,0.475580723,4.2226101413,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3895,6272,1.44431531,0.9944375797,2.0977150879,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1062,5024,0.993105474,0.6459895912,1.5267405171,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,834,1753,1.4295097864,0.4765492259,4.2881157251,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3895,6272,1.4509689965,0.9991039001,2.1071992899,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1062,5024,1.0011637343,0.6468343121,1.5495913005,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,834,1753,1.4095890865,0.4720603052,4.2090838205,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3895,6272,1.4430225806,0.993960101,2.0949675606,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1062,5024,0.987589891,0.6413857006,1.5206665692,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,834,1753,1.4423381614,0.4815924633,4.3197091531,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3895,6272,1.4556491721,1.0020279304,2.1146261975,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1062,5024,1.0096672798,0.6503046031,1.5676161771,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,834,1753,1.4020287747,0.4768452264,4.1222698187,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3895,6272,1.4236109181,0.9778486779,2.072578398,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1062,5024,0.9923136438,0.6451711964,1.5262404353,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,818,1748,1.8133291533,1.0324414602,3.1848417028,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3785,6207,1.7721129478,1.374043054,2.2855064773,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1056,5093,1.6910055275,1.2435448321,2.2994745508,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,818,1748,1.2869407251,0.6730856645,2.4606324534,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3785,6207,1.619332166,1.2075693457,2.1714998588,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1056,5093,1.0644137164,0.7083928072,1.5993620322,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,818,1748,1.2850224966,0.6719808738,2.4573360361,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3785,6207,1.6188587024,1.2067437527,2.1717149912,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1056,5093,1.0657103181,0.7091933603,1.6014510932,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,818,1748,1.2833497942,0.6705342037,2.4562306966,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3785,6207,1.6175848498,1.2054041583,2.1707082461,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1056,5093,1.0603203609,0.7079404041,1.5880987455,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,818,1748,1.286824388,0.6730454254,2.4603346863,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3785,6207,1.6194167479,1.2076087152,2.17165591,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1056,5093,1.0617534483,0.7071533748,1.5941667327,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,818,1748,1.2817587527,0.6696494466,2.453381405,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3785,6207,1.6178684516,1.2051576814,2.1719135737,1,1
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1056,5093,1.0590849081,0.7075538452,1.5852657012,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,818,1748,1.2750325716,0.6654448952,2.4430393418,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3785,6207,1.6077735981,1.1985426008,2.156732636,1,1
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1056,5093,1.0568400226,0.7028933121,1.5890190078,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,788,1725,2.0928803588,1.2766674353,3.4309234146,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3679,6147,1.7056979945,1.349234443,2.1563381098,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1010,5107,3.3459073848,2.3351048256,4.7942585296,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,788,1725,1.8888931656,0.9543530284,3.7385718751,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3679,6147,1.6620166238,1.2719258616,2.1717454935,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1010,5107,3.8943791769,2.3594459884,6.4278602891,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,788,1725,1.8732733357,0.9454741526,3.7115271534,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3679,6147,1.6594623163,1.2706189192,2.1673022002,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1010,5107,3.8861164422,2.3576004359,6.4056236047,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,788,1725,1.918732005,0.9695108155,3.797309373,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3679,6147,1.6716385348,1.278577843,2.1855340341,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1010,5107,3.9734619934,2.3930352331,6.5976463675,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,788,1725,1.8889630839,0.9544105914,3.7386231509,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3679,6147,1.6623701221,1.2722876989,2.1720515143,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1010,5107,3.8835542207,2.3550396006,6.4041357865,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,788,1725,1.8998884106,0.9583214681,3.766560693,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3679,6147,1.6679157696,1.2759661737,2.1802639223,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1010,5107,3.9743302162,2.3934375454,6.5994204435,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,788,1725,1.8707995361,0.9437479586,3.7085016953,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3679,6147,1.6543975464,1.2667300884,2.1607059519,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1010,5107,3.8895984428,2.3588909063,6.4135971723,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,797,1718,0.9563392069,0.5997934677,1.5248326765,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3707,6141,1.28235618,1.0449815748,1.573652026,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1069,5143,2.8487530759,1.994566057,4.0687517263,1,1
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,797,1718,0.6031901178,0.3407630118,1.0677165819,1,0
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3707,6141,1.2119724229,0.9555186185,1.5372564442,1,0
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1069,5143,3.3427306093,1.9880774853,5.6204287855,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,797,1718,0.5998735191,0.3386488536,1.0625999026,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3707,6141,1.2138941612,0.9575486866,1.5388659138,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1069,5143,3.3469199949,1.9940339138,5.617694551,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,797,1718,0.5990850276,0.3377924963,1.0624950943,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3707,6141,1.2077371494,0.9513033952,1.5332952971,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1069,5143,3.3121220284,1.95838771,5.6016243742,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,797,1718,0.6031545886,0.3407412249,1.0676590654,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3707,6141,1.2131447788,0.956383513,1.5388390059,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1069,5143,3.3499966359,1.9932787632,5.6301595482,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,797,1718,0.5968113363,0.3365339143,1.0583889348,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3707,6141,1.2114056061,0.9549147789,1.5367900624,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1069,5143,3.3200815671,1.965107611,5.6093323087,1,1
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,797,1718,0.5972725603,0.337107736,1.0582210764,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3707,6141,1.207541471,0.9523313063,1.5311440405,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1069,5143,3.3281526498,1.9775651251,5.6011303597,1,1
